1. Home
  2. GHRS vs AMN Comparison

GHRS vs AMN Comparison

Compare GHRS & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • AMN
  • Stock Information
  • Founded
  • GHRS 2018
  • AMN 1985
  • Country
  • GHRS Ireland
  • AMN United States
  • Employees
  • GHRS N/A
  • AMN N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • AMN Assisted Living Services
  • Sector
  • GHRS Health Care
  • AMN Health Care
  • Exchange
  • GHRS Nasdaq
  • AMN Nasdaq
  • Market Cap
  • GHRS 960.2M
  • AMN 840.0M
  • IPO Year
  • GHRS 2021
  • AMN 2001
  • Fundamental
  • Price
  • GHRS $14.38
  • AMN $18.43
  • Analyst Decision
  • GHRS Strong Buy
  • AMN Hold
  • Analyst Count
  • GHRS 8
  • AMN 8
  • Target Price
  • GHRS $30.63
  • AMN $31.92
  • AVG Volume (30 Days)
  • GHRS 353.0K
  • AMN 664.2K
  • Earning Date
  • GHRS 09-02-2025
  • AMN 08-07-2025
  • Dividend Yield
  • GHRS N/A
  • AMN N/A
  • EPS Growth
  • GHRS N/A
  • AMN N/A
  • EPS
  • GHRS N/A
  • AMN N/A
  • Revenue
  • GHRS N/A
  • AMN $2,852,436,000.00
  • Revenue This Year
  • GHRS N/A
  • AMN N/A
  • Revenue Next Year
  • GHRS N/A
  • AMN $1.83
  • P/E Ratio
  • GHRS N/A
  • AMN N/A
  • Revenue Growth
  • GHRS N/A
  • AMN N/A
  • 52 Week Low
  • GHRS $6.00
  • AMN $17.45
  • 52 Week High
  • GHRS $20.50
  • AMN $70.07
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 46.75
  • AMN 34.94
  • Support Level
  • GHRS $12.81
  • AMN $19.47
  • Resistance Level
  • GHRS $15.28
  • AMN $20.13
  • Average True Range (ATR)
  • GHRS 1.49
  • AMN 0.87
  • MACD
  • GHRS -0.41
  • AMN -0.19
  • Stochastic Oscillator
  • GHRS 20.60
  • AMN 2.05

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About AMN AMN Healthcare Services Inc

AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.

Share on Social Networks: